Immune Design Corp.
Records under this name other than the patents Immune Design Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 5 of 5 · Back to Immune Design Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,365,230 | Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof Lapsed on the fee record Ended Jun 21, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 21, 2026 | From the USPTO record |
| US 11,135,283 | Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids Lapsed on the fee record Ended Oct 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 5, 2025 | From the USPTO record |
| US 9,713,635 | Materials and methods for producing improved lentiviral vector particles Lapsed on the fee record Ended Jul 25, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 25, 2025 | From the USPTO record |
| US 10,993,999 | Materials and methods for producing improved lentiviral vector particles Lapsed on the fee record Ended May 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2025 | From the USPTO record |
| US 8,323,662 | Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein Lapsed on the fee record Ended Dec 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2024 | From the USPTO record |